The device was not returned for evaluation.A review of the lot history record of the reported lot could not be conducted because the lot number was not provided.The reported patient effects of stenosis, occlusion and pain are listed in the supera peripheral stent systems instructions for use as potential adverse effects.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatments appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.B3: date of event estimated as 05/10/2022.
|
It was reported the 4.50x120mm supera stent was implanted in the popliteal bypass on (b)(6) 2021.Six months post procedure, the patient presented with pain in the leg and in-stent stenosis was noted, which was treated with a drug coated balloon.A few months later, the supera stent was occluded.The physician decided to not treat the occlusion as the patient has many collaterals that allow blood flow.No additional information was provided.
|